Asymmetric dimethylarginine levels in patients with coronary artery ectasia

Cay S., Cagirci G., Akcay M., Karakurt O., Kahraman E., YAZIHAN N., ...More

KARDIOLOGIA POLSKA, vol.67, no.12, pp.1362-1370, 2009 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 67 Issue: 12
  • Publication Date: 2009
  • Journal Name: KARDIOLOGIA POLSKA
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1362-1370
  • Keywords: asymmetric dimethylarginine, coronary artery ectasia, endothelial dysfunction, CLINICAL-SIGNIFICANCE, FRAME COUNT, ADMA, DYSFUNCTION, ANEURYSMS, PLASMA, RISK, HPLC
  • Ankara University Affiliated: Yes

Abstract

Background: Endothelial dysfunction might be one of the pathophysiological mechanisms in the development of coronary artery ectasia (CAE) although the exact mechanisms have not yet been demonstrated. Asymmetric dimethylarginine (ADMA), an endogenous competitive inhibitor of nitric oxide synthase, is also related to endothelial and structural dysfunction.